These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 23513847)

  • 1. [TGF-beta signaling as a target of therapy].
    Komuro A; Miyazono K
    Nihon Rinsho; 2012 Nov; 70 Suppl 8():256-62. PubMed ID: 23513847
    [No Abstract]   [Full Text] [Related]  

  • 2. TGF-β/TGF-β receptor system and its role in physiological and pathological conditions.
    Santibañez JF; Quintanilla M; Bernabeu C
    Clin Sci (Lond); 2011 Sep; 121(6):233-51. PubMed ID: 21615335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of TGF-beta signalling inhibitors for cancer therapy.
    Yingling JM; Blanchard KL; Sawyer JS
    Nat Rev Drug Discov; 2004 Dec; 3(12):1011-22. PubMed ID: 15573100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
    Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular biology in regulation of kidney function: TGF-beta (transforming growth factor-beta)].
    Tamaki K; Yoshimura J; Okuda S
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():297-301. PubMed ID: 16523906
    [No Abstract]   [Full Text] [Related]  

  • 6. [Transforming growth factor-beta signaling and cancer].
    Miyazono K
    Hum Cell; 2000 Sep; 13(3):97-101. PubMed ID: 11197777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells.
    Matsuyama S; Iwadate M; Kondo M; Saitoh M; Hanyu A; Shimizu K; Aburatani H; Mishima HK; Imamura T; Miyazono K; Miyazawa K
    Cancer Res; 2003 Nov; 63(22):7791-8. PubMed ID: 14633705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. alpha2HS-glycoprotein, an antagonist of transforming growth factor beta in vivo, inhibits intestinal tumor progression.
    Swallow CJ; Partridge EA; Macmillan JC; Tajirian T; DiGuglielmo GM; Hay K; Szweras M; Jahnen-Dechent W; Wrana JL; Redston M; Gallinger S; Dennis JW
    Cancer Res; 2004 Sep; 64(18):6402-9. PubMed ID: 15374947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted TGF-beta chemotherapies: friend or foe in treating human malignancies?
    Schiemann WP
    Expert Rev Anticancer Ther; 2007 May; 7(5):609-11. PubMed ID: 17492924
    [No Abstract]   [Full Text] [Related]  

  • 10. Negative regulation of TGF-beta signaling in development.
    Chen YG; Meng AM
    Cell Res; 2004 Dec; 14(6):441-9. PubMed ID: 15625010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [TGF-beta signaling pathway in pancreatic cancer cells].
    Ijichi H
    Nihon Rinsho; 2004 Jul; 62(7):1241-8. PubMed ID: 15283139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective TGF-beta signaling sensitizes human cancer cells to rapamycin.
    Gadir N; Jackson DN; Lee E; Foster DA
    Oncogene; 2008 Feb; 27(8):1055-62. PubMed ID: 17700525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal transduction by transforming growth factor-beta: a cooperative paradigm with extensive negative regulation.
    Engel ME; Datta PK; Moses HL
    J Cell Biochem Suppl; 1998; 30-31():111-22. PubMed ID: 9893262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dynamic roles of TGF-β in cancer.
    Meulmeester E; Ten Dijke P
    J Pathol; 2011 Jan; 223(2):205-18. PubMed ID: 20957627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolutionally conserved activity of Dapper2 in antagonizing TGF-beta signaling.
    Su Y; Zhang L; Gao X; Meng F; Wen J; Zhou H; Meng A; Chen YG
    FASEB J; 2007 Mar; 21(3):682-90. PubMed ID: 17197390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-beta signalling in colon carcinogenesis.
    Lampropoulos P; Zizi-Sermpetzoglou A; Rizos S; Kostakis A; Nikiteas N; Papavassiliou AG
    Cancer Lett; 2012 Jan; 314(1):1-7. PubMed ID: 22018778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of cytokine signaling pathways of the transforming growth factor-beta (TGF-beta) family in the regulation of hematopoiesis].
    Fuchs O
    Cas Lek Cesk; 2002 Sep; 141 Suppl():18-22. PubMed ID: 12428417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta-induced inhibition of myogenesis is mediated through Smad pathway and is modulated by microtubule dynamic stability.
    Zhu S; Goldschmidt-Clermont PJ; Dong C
    Circ Res; 2004 Mar; 94(5):617-25. PubMed ID: 14739161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Can defective TGF-Beta signaling be an Achilles heel in human cancer?].
    Foster DA; Gadir N
    Ai Zheng; 2008 Aug; 27(8):882-4. PubMed ID: 18710627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta: the breaking open of a black box.
    Alevizopoulos A; Mermod N
    Bioessays; 1997 Jul; 19(7):581-91. PubMed ID: 9230691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.